RIOK2
Basic information
Region (hg38): 5:97160867-97183247
Links
Phenotypes
GenCC
Source:
- male infertility with azoospermia or oligozoospermia due to single gene mutation (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RIOK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 22 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 1 | 3 |
Variants in RIOK2
This is a list of pathogenic ClinVar variants found in the RIOK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-97163077-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
5-97163122-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
5-97163136-T-C | not specified | Uncertain significance (Oct 03, 2023) | ||
5-97163200-C-T | Benign (Apr 24, 2018) | |||
5-97163231-A-G | Benign (Apr 24, 2018) | |||
5-97165077-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
5-97167473-G-A | not specified | Uncertain significance (Oct 04, 2022) | ||
5-97167475-C-A | not specified | Uncertain significance (Mar 25, 2024) | ||
5-97167500-A-G | not specified | Uncertain significance (Nov 07, 2022) | ||
5-97167530-T-C | not specified | Uncertain significance (Nov 24, 2021) | ||
5-97167551-A-G | not specified | Uncertain significance (Feb 28, 2023) | ||
5-97167603-T-G | not specified | Uncertain significance (May 30, 2024) | ||
5-97167645-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
5-97167651-C-G | not specified | Uncertain significance (Jun 17, 2024) | ||
5-97167887-A-G | not specified | Likely benign (Dec 28, 2023) | ||
5-97167897-C-G | not specified | Uncertain significance (May 08, 2023) | ||
5-97167978-G-C | not specified | Uncertain significance (Jun 22, 2021) | ||
5-97171216-T-G | not specified | Uncertain significance (Dec 13, 2023) | ||
5-97171313-C-T | Benign (Apr 10, 2018) | |||
5-97177175-T-C | not specified | Uncertain significance (Mar 20, 2023) | ||
5-97177183-T-C | Benign (Jun 18, 2018) | |||
5-97177257-T-G | not specified | Uncertain significance (Feb 28, 2023) | ||
5-97177271-C-G | not specified | Uncertain significance (Dec 18, 2023) | ||
5-97177755-T-A | not specified | Uncertain significance (Aug 08, 2022) | ||
5-97177761-C-A | not specified | Uncertain significance (Mar 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RIOK2 | protein_coding | protein_coding | ENST00000283109 | 10 | 22394 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000134 | 0.998 | 125691 | 0 | 55 | 125746 | 0.000219 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.850 | 246 | 287 | 0.859 | 0.0000147 | 3646 |
Missense in Polyphen | 63 | 81.197 | 0.77589 | 946 | ||
Synonymous | 0.389 | 92 | 96.9 | 0.950 | 0.00000485 | 979 |
Loss of Function | 2.75 | 11 | 26.2 | 0.420 | 0.00000124 | 360 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000252 | 0.000249 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000551 | 0.0000544 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000337 | 0.000334 |
Middle Eastern | 0.0000551 | 0.0000544 |
South Asian | 0.000264 | 0.000261 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase involved in the final steps of cytoplasmic maturation of the 40S ribosomal subunit. Involved in export of the 40S pre-ribosome particles (pre-40S) from the nucleus to the cytoplasm. Its kinase activity is required for the release of NOB1, PNO1 and LTV1 from the late pre-40S and the processing of 18S-E pre-rRNA to the mature 18S rRNA (PubMed:19564402). Regulates the timing of the metaphase-anaphase transition during mitotic progression, and its phosphorylation, most likely by PLK1, regulates this function (PubMed:21880710). {ECO:0000269|PubMed:16037817, ECO:0000269|PubMed:19564402, ECO:0000269|PubMed:21880710}.;
- Pathway
- Ribosome biogenesis in eukaryotes - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.0917
Intolerance Scores
- loftool
- 0.985
- rvis_EVS
- 1.07
- rvis_percentile_EVS
- 91.61
Haploinsufficiency Scores
- pHI
- 0.640
- hipred
- Y
- hipred_score
- 0.622
- ghis
- 0.504
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.813
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Riok2
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- cell cycle;regulation of mitotic metaphase/anaphase transition;maturation of SSU-rRNA;ribosomal small subunit biogenesis;protein autophosphorylation;positive regulation of ribosomal small subunit export from nucleus;positive regulation of rRNA processing
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol;preribosome, small subunit precursor
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;metal ion binding